Citation Impact
Citing Papers
Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-X L
2019
Degradation of proteins by PROTACs and other strategies
2019
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
2021
Quinoxaline, its derivatives and applications: A State of the Art review
2014 Standout
Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity
2022 Standout
Identification of natural inhibitors of Entamoeba histolytica cysteine synthase from microbial secondary metabolites
2015 StandoutNobel
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
2020
Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets
2020
Indole synthesis: a review and proposed classification
2011 Standout
Synthesis, characterization and in vitro antibacterial activity of new steroidal thiazolo quinoxalines
2006
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
2020 Standout
The stimulation of thrombosis by hypoxia
2019
Targeting apoptosis in cancer therapy
2020 Standout
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Kinase inhibitors: the road ahead
2018
In vitro and in vivo degradation of programmed cell death ligand 1 (PD-L1) by a proteolysis targeting chimera (PROTAC)
2021
CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax
2019
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
2020 Standout
Harnessing the Power of Proteolysis for Targeted Protein Inactivation
2020
Synthesis and antimicrobial activity of (1,4-phenylene)bis(arylsulfonylpyrazoles and isoxazoles)
2013
Transforming targeted cancer therapy with PROTACs: A forward-looking perspective
2021
Potentiality of vanadium compounds as anti-parasitic agents
2011
3d Transition Metals for C–H Activation
2018 Standout
Current Therapeutics, Their Problems, and Sulfur-Containing-Amino-Acid Metabolism as a Novel Target against Infections by “Amitochondriate” Protozoan Parasites
2007
State of the Art and Prospects in Metal–Organic Framework (MOF)-Based and MOF-Derived Nanocatalysis
2019 Standout
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Versatile Synthesis of Quinoline-3-Carboxylic Esters and Indol-2-Acetic Esters by Palladium-Catalyzed Carbonylation of 1-(2-Aminoaryl)-2-Yn-1-Ols
2008
Chemistry and Biology of Synthetic and Naturally Occurring Antiamoebic Agents
2009
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Palladium coordination compounds as anti-viral, anti-fungal, anti-microbial and anti-tumor agents
2008
Chalcones: Synthetic Chemistry Follows Where Nature Leads
2021
The Use of N‐Type Ligands in the Enantioselective Liquid–Liquid Extraction of Underivatized Amino Acids
2010 StandoutNobel
Works of Mohammad Abid being referenced
Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy
2015
Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin
2012
1--Substituted Thiocarbamoyl-3-Phenyl-2-Pyrazolines: Synthesis and In Vitro Antiamoebic Activities
2005
Synthesis and antiamoebic activities of 1-N-substituted cyclised pyrazoline analogues of thiosemicarbazones
2005
Syntheses, characterization and in vitro antiamoebic activity of new Pd(II) complexes with 1-N-substituted thiocarbamoyl-3,5-diphenyl-2-pyrazoline derivatives
2006
Synthesis, characterization and antiamoebic activity of new indole-3-carboxaldehyde thiosemicarbazones and their Pd(II) complexes
2007
Synthesis and antiamoebic activity of new oxime ether derivatives containing 2-acetylpyridine/2-acetylfuran
2005
Synthesis and antiamoebic activity of new 1-N-substituted thiocarbamoyl-3,5-diphenyl-2-pyrazoline derivatives and their Pd(II) complexes
2005
Synthesis and Anti-Amoebic Activity of Gold(I), Ruthenium(II), and Copper(II) Complexes of Metronidazole
2005
Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(iv ), oxovanadium(v ) and µ-bis(oxo)bis{oxovanadium(v )} complexes
2005
Synthesis, characterization and antiamoebic activity of 1-(thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazoline derivatives
2006
Dioxovanadium(V) and μ-oxo bis[oxovanadium(V)] complexes containing thiosemicarbazone based ONS donor set and their antiamoebic activity
2006
Facile synthesis of chalcone derivatives as antibacterial agents: Synthesis, DNA binding, molecular docking, DFT and antioxidant studies
2020
Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein
2018
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)
2017